Title
Category
Credits
Event date
Cost
What Is Cancer Rehabilitation and How Can it Help My Patients?
  • Advanced Practice Provider
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Sasha E. Knowlton, MD, presents an introduction to cancer rehabilitation, including details as to why function is important in cancer patients. Patients with cancer are living longer as a result of improved surveillance and treatment interventions. However, cancer survivors often develop functional impairments that can significantly affect their quality of life and independence. Dr. Knowlton will review common diagnoses and treatments in the field of cancer rehabilitation. She will also provide an overview of how cancer rehabilitation can help patients before and during treatment and into survivorship.
Oral Chemotherapy: Prescribing, Monitoring, and Safety
  • Advanced Practice Provider
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Oral chemotherapy has shifted the care of oncology patients from infusion clinics to patients' homes. This shift in care requires healthcare providers to not only manage patients differently but for patients to take on additional responsibilities. Aimee Faso, PharmD, BCOP, CPP, addresses the issues related to the safe use of oral chemotherapy in oncology patients.
The Value of Integrative Medicine in Oncology Care
  • Advanced Practice Provider
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Denise Spector, PhD, MPH, ANP, RYT, provides an overview of integrative oncology which includes evidence-based strategies for helping to mitigatecommon cancer symptoms and cancer treatment-related side effects, as well as strategies that may improve one's overall healthand well-being along the cancer care continuum.
GVHD: An Overview of Graft vs Host Disease Post Hematopoietic Stem Cell Transplant
  • Advanced Practice Provider
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Megan McElfresh, PA-C, provides an overview of the pathophysiology, diagnosis, prevention, and treatment of graft vs host disease post hematopoietic stem cell transplant.
Radiation Oncology Management of Lung Cancer in NC: Update on Small-Cell Lung Cancer
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Ashley Weiner, MD, PhD, presents on the role of radiotherapy for small-cell lung cancer. She provides overview of radiation oncology, and a walk through a patient's pathway from initial consultation with a radiation oncologist to treatment and follow-up. Finally, she reviews the indications for, logistics of, and side effects of radiation for the treatment of small cell lung cancer (limited and extensive stage).
The Ketogenic Diet for Brain Tumor Patients: A Phase 1 Trial and Beyond...
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.
Multidisciplinary/Multimodality Management of Locally Recurrent Rectal Cancer - SPOC
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 Participation
$0.00
Jose Gaston Guillem, MD, MPH, MBA, will describe how at UNC Medical Center a team of experts carefully reviews each individual patient during a Weekly GI Tumor Board and collaboratively develop a treatment plan which defines the specific timing and sequence of care for each patient.
Clinical Updates in Breast Oncology - SPOC
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Innovations in breast oncology can translate to improved patient outcomes for patients with early and late-stage disease. In this webinar, Dr. Ray will discuss the latest research findings and how they can be translated into the clinical care of patients with breast cancer.
Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC): An Evolving Diagnostic and Therapeutic Paradigm
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 CTR Category A
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Joshua F. Zeidner, MD, will discuss the evolving diagnostic algorithm for AML-MRC, prognosis, treatment outcomes, and unmet needs.
Cardiovascular Toxicities of Cancer Therapies
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Brian Colwell Jensen, MD, will introduce the audience to potential cardiovascular adverse effects of contemporary cancer therapeutics.

Pages